Zai Lab (ZLAB) Common Equity (2016 - 2026)

Zai Lab (ZLAB) has reported Common Equity for 11 consecutive years, with $662.0 million the latest figure, recorded in Q1 2026.

• Quarterly Common Equity fell 18.35% year-over-year to $662.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $662.0 million (down 18.35% YoY) and the FY2025 annual result came in at $715.5 million, down 14.91% from the prior year.
• Common Equity declined to $662.0 million in Q1 2026 per ZLAB's latest filing, from $715.5 million in the prior quarter.
• Over the last five years, Common Equity for ZLAB reached as high as $1.3 billion in Q1 2022 and fell as low as $662.0 million in Q1 2026.
• A 5-year average of $882.2 million and a median of $810.8 million in 2025 frame the typical range for Common Equity.
• The largest YoY upside for Common Equity was 29.55% in 2022 against a maximum downside of 30.36% in 2022.
• Year by year, Common Equity stood at $1.0 billion in 2022, then slipped by 23.86% to $796.1 million in 2023, then grew by 5.62% to $840.9 million in 2024, then slipped by 14.91% to $715.5 million in 2025, then fell by 7.48% to $662.0 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $662.0 million, $715.5 million, and $759.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.